93 related articles for article (PubMed ID: 11450742)
1. Bilateral poliosis and granulomatous anterior uveitis associated with latanoprost use and apparent hypotrichosis on its withdrawal.
Waheed K; Laganowski H
Eye (Lond); 2001 Jun; 15(Pt 3):347-9. PubMed ID: 11450742
[No Abstract] [Full Text] [Related]
2. Anterior uveitis associated with fixed-combination latanoprost and timolol.
Ornek K; Onaran Z; Turgut Y
Can J Ophthalmol; 2008 Dec; 43(6):727-8. PubMed ID: 19020649
[No Abstract] [Full Text] [Related]
3. Topical prostaglandin F(2alpha) analog induced poliosis.
Chen CS; Wells J; Craig JE
Am J Ophthalmol; 2004 May; 137(5):965-6. PubMed ID: 15126178
[TBL] [Abstract][Full Text] [Related]
4. Five-year, multicenter safety study of fixed-combination latanoprost/timolol (Xalacom) for open-angle glaucoma and ocular hypertension.
Alm A; Grunden JW; Kwok KK
J Glaucoma; 2011; 20(4):215-22. PubMed ID: 20520568
[TBL] [Abstract][Full Text] [Related]
5. Granulomatous anterior uveitis associated with 0.2% topical brimonidine.
Cates CA; Jeffrey MN
Eye (Lond); 2003 Jul; 17(5):670-1. PubMed ID: 12855989
[No Abstract] [Full Text] [Related]
6. Hypertrichosis of the malar areas and poliosis of the eyelashes caused by latanoprost.
Özyurt S; Çetinkaya GS
Actas Dermosifiliogr; 2015; 106(1):74-5. PubMed ID: 25065768
[No Abstract] [Full Text] [Related]
7. CME and anterior uveitis with latanoprost use.
Thorne JE; Maguire AM; Lanciano R
Ophthalmology; 1998 Nov; 105(11):1981-3. PubMed ID: 9818590
[No Abstract] [Full Text] [Related]
8. Anterior uveitis associated with latanoprost.
Fechtner RD; Khouri AS; Zimmerman TJ; Bullock J; Feldman R; Kulkarni P; Michael AJ; Realini T; Warwar R
Am J Ophthalmol; 1998 Jul; 126(1):37-41. PubMed ID: 9683147
[TBL] [Abstract][Full Text] [Related]
9. A randomised, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open angle glaucoma.
Nagar M; Ogunyomade A; O'Brart DP; Howes F; Marshall J
Br J Ophthalmol; 2005 Nov; 89(11):1413-7. PubMed ID: 16234442
[TBL] [Abstract][Full Text] [Related]
10. Systemic side effects of topical latanoprost.
Rajan MS; Syam P; Liu C
Eye (Lond); 2003 Apr; 17(3):442-4. PubMed ID: 12724721
[No Abstract] [Full Text] [Related]
11. Latanoprost and hyperpigmentation of eyelashes.
Wand M
Arch Ophthalmol; 1997 Sep; 115(9):1206-8. PubMed ID: 9298071
[No Abstract] [Full Text] [Related]
12. Bilateral severe fibrinous anterior uveitis--an unusual complication of pamidronate therapy exacerbated by topical latanoprost.
Ramasamy B; Quah S; Sahni JN; Palimar P
J Ocul Pharmacol Ther; 2007 Oct; 23(5):513-5. PubMed ID: 17900233
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the additive effect of bunazosin on latanoprost in primary open-angle glaucoma.
Maruyama K; Shirato S; Haneda M
Jpn J Ophthalmol; 2005; 49(1):61-2. PubMed ID: 15692779
[No Abstract] [Full Text] [Related]
14. Severe hypotony following cataract extraction in a patient on latanoprost.
Wu G; Morrell A
Eye (Lond); 2000 Dec; 14(Pt 6):915-6. PubMed ID: 11584861
[No Abstract] [Full Text] [Related]
15. Side effects associated with prostaglandin analog therapy.
Alm A; Grierson I; Shields MB
Surv Ophthalmol; 2008 Nov; 53 Suppl1():S93-105. PubMed ID: 19038628
[TBL] [Abstract][Full Text] [Related]
16. A correlation between latanoprost-induced conjunctival hyperemia and intraocular pressure-lowering effect.
Kobayashi H; Kobayashi K
J Glaucoma; 2011 Jan; 20(1):3-6. PubMed ID: 20520573
[TBL] [Abstract][Full Text] [Related]
17. Herpes simplex dendritic keratitis after treatment with latanoprost for primary open angle glaucoma.
Ekatomatis P
Br J Ophthalmol; 2001 Aug; 85(8):1008-9. PubMed ID: 11501520
[No Abstract] [Full Text] [Related]
18. Intermittent blurred vision and trichomegaly due to latanoprost.
Woo TL; Francis IC
Clin Exp Ophthalmol; 2001 Aug; 29(4):272-3. PubMed ID: 11545432
[No Abstract] [Full Text] [Related]
19. [Latanoprost (Xalatan) and a systemic respiratory effect? Apropos of a case].
Veyrac G; Chiffoleau A; Cellerin L; Larousse C; Bourin M
Therapie; 1999; 54(4):494-6. PubMed ID: 10667120
[No Abstract] [Full Text] [Related]
20. A prospective study of iridial pigmentation and eyelash changes due to ophthalmic treatment with latanoprost.
Chiba T; Kashiwagi K; Ishijima K; Furuichi M; Kogure S; Abe K; Chiba N; Tsukahara S
Jpn J Ophthalmol; 2004; 48(2):141-7. PubMed ID: 15060793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
